Gubra
644 DKK +14,18%HC Andersen Capital modtager betaling fra Gubra for en Digital IR/Corporate Visibility abonnementsaftale. Læs mere her.
17 investorer følger denne virksomhed
Gubra er en medicinalvirksomhed. Virksomhedens aktiviteter er fokuseret på de tidlige stadier af lægemiddeludvikling. De udfører hovedsageligt forskning og udvikling inden for stofskifte- og fibrotiske sygdomme.Virksomhedens produktportefølje omfatter flere brands og lægemidler, og aktiviteterne foregår på globalt plan med den største tilstedeværelse i Nordamerika og Norden. Hovedkontoret ligger i Hørsholm, Danmark.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Copenhagen
GUBRA
Daglig lav / høj pris
564 / 644
DKK
Markedsværdi
10,53 mia. DKK
Aktieomsætning
82,36 mio. DKK
Volumen
134 t
Seneste analyser
Seneste videoer
Finanskalender
Delårsrapport
23.08.2024
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Niels Vrang | 30,6 % | 30,6 % |
Jacob Jelsing | 27,5 % | 27,5 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
![Dagens aktienyheder 03/07: Gubra, Scandinavian Medical Solutions og Agillic](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/deb229a0-0cf0-44d2-83cf-e49611d35e48.png)
Dagens aktienyheder 03/07: Gubra, Scandinavian Medical Solutions og Agillic
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
![Dagens aktienyheder 02/07: Gubra, BioPorto A/S, Asetek og ExpreS2ion Biotechnologies](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/7f9f70e3-5d96-458f-a253-69d99d5b84ee.png)
Dagens aktienyheder 02/07: Gubra, BioPorto A/S, Asetek og ExpreS2ion Biotechnologies
![Gubra: Share price moves to all-time high as another partner project enters phase 1](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/1a731c70-ce2b-4bad-8a7d-91a54df60081.png)
Gubra: Share price moves to all-time high as another partner project enters phase 1
Boehringer Ingelheim and Gubra announce start of clinical development of a potential first-in-class, triple agonist, obesity treatment
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares
![Dagens aktienyheder 25/6: Scandinavian Medical Solutions, Gubra og BioPorto](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/02ce841d-d050-4d1c-a0c1-d0bf000984c1.png)
Dagens aktienyheder 25/6: Scandinavian Medical Solutions, Gubra og BioPorto
![Gubra (One-pager): Very high investor confidence in Gubra’s ability to bring obesity products to the market](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/1a731c70-ce2b-4bad-8a7d-91a54df60081.png)
Gubra (One-pager): Very high investor confidence in Gubra’s ability to bring obesity products to the market
![Gubra - Presentation of Q2 report 2024](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/16208bfa-2ad2-4b1c-b697-48033a26e6ba.png)
Gubra - Presentation of Q2 report 2024
![HCA Capital: Wrap up from 2024 Life Science seminar](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/ab49c0b1-56d0-4e1c-b729-6c79c89b7be2.png)
HCA Capital: Wrap up from 2024 Life Science seminar
![Dagens aktienyheder 5/6: Agillic, GreenMobility A/S og Gubra](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/d23dc945-4282-4b19-aed8-17ba52ed8d75.png)
Dagens aktienyheder 5/6: Agillic, GreenMobility A/S og Gubra
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares
![Life Science seminar 2024](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/ab49c0b1-56d0-4e1c-b729-6c79c89b7be2.png)
Life Science seminar 2024
![Dagens aktienyheder 3/6: RTX A/S, Asetek, Ascelia Pharma AB, Pharma Equity Group A/S, Gubra og ExpreS2ion Biotech](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/8e35221b-ab03-4e96-85e7-32c5d1f6cfe4.png)
Dagens aktienyheder 3/6: RTX A/S, Asetek, Ascelia Pharma AB, Pharma Equity Group A/S, Gubra og ExpreS2ion Biotech
![Dagens aktienyheder 27/5/2024: Gubra, SP Group, Boozt, Impero, GrønlandsBANKEN og Gabriel](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/b776ceda-a13a-47a4-b200-3c852eaddaac.png)
Dagens aktienyheder 27/5/2024: Gubra, SP Group, Boozt, Impero, GrønlandsBANKEN og Gabriel
![Gubra: Fase 1 forsøg med GUBamy går som planlagt](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/1a731c70-ce2b-4bad-8a7d-91a54df60081.png)
Gubra: Fase 1 forsøg med GUBamy går som planlagt
![Dagens aktienyheder 08/05: TORM, BioPorto A/S, Skjern Bank og Gubra](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/4978f369-a4da-4696-bf44-cf66dd86326e.png)
Dagens aktienyheder 08/05: TORM, BioPorto A/S, Skjern Bank og Gubra
![Gubra: Another quarter, another upgrade, and a new all-time high for the stock](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/54f1598f-9196-4486-a9e6-fb7a93cd91f7.png)